首页> 外文OA文献 >From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents

【2h】

From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents

机译：从癌基因到药物：小分子酪氨酸激酶抑制剂作为抗肿瘤和抗血管生成剂的发展

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Michael J Morin;
展开▼
作者单位

展开▼
年度 2000
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinase [J] . AwazuY., MizutaniA., NagaseY., Cancer science. . 2013,第4期

机译：TAK-593（血管内皮生长因子和血小板源性生长因子受体酪氨酸激酶的有效和选择性抑制剂）的抗血管生成和抗肿瘤作用
2. In vitro pharmacological characterization of TKI-28, a broad-spectrum tyrosine kinase inhibitor with anti-tumor and anti-angiogenic effects. [J] . Guo XN, Zhong L, Tan JZ, Cancer biology & therapy . 2005,第10期

机译：TKI-28的体外药理学表征，TKI-28是一种具有抗肿瘤和抗血管生成作用的广谱酪氨酸激酶抑制剂。
3. Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors [J] . Eleanor Gutteridge, John FR Robertson Breast Cancer Research . 2009,第Suppla3期

机译：当前的药物开发计划是否能充分发挥新药的潜力？酪氨酸激酶抑制剂
4. Identification and Characterization of Synthetic Peptide Substrates and Small Molecule Inhibitors of Non Receptor Tyrosine Kinase Etk [C] . Lauren Lee, Ruiwu Liu, Nianhuan Yao American Peptide Symposium . 2006

机译：非受体酪氨酸激酶ETK的合成肽底物和小分子抑制剂的鉴定与表征
5. Changing the Drug Exposure of Small Molecule Tyrosine Kinase Inhibitors. [D] . Yago, Marc Anthony R. 2015

机译：改变小分子酪氨酸激酶抑制剂的药物暴露。
6. Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors [O] . Eleanor Gutteridge, John FR Robertson 2009

机译：当前的药物开发计划是否能充分发挥新药的潜力？酪氨酸激酶抑制剂
7. Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors [O] . Gutteridge, Eleanor, Robertson, John FR 2009

机译：当前的药物开发计划是否能充分发挥新药的潜力？酪氨酸激酶抑制剂
8. Egf Receptor Mabs and Chemotherapy/Characterization of Synergistic Interactions Between Cyrotoxic Agents and Inhibitors of the Tyrosine Kinase Growth Factor Receptor Signaling Cascade [R] . Seidman, A. 1999

机译：Egf受体单克隆抗体和化学疗法/ Cyrotoxic剂与酪氨酸激酶生长因子受体信号级联抑制剂之间协同相互作用的表征

From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents

著录项

引文网络

相似文献

相关主题

期刊订阅